Stock Track | Avidity Biosciences (RNA) Soars 11.23% Pre-Market on HC Wainwright's Buy Rating Maintenance

Stock Track

May 12, 2025

Shares of Avidity Biosciences, Inc. (RNA) are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its "Buy" rating on the company.

The maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have sparked renewed interest among investors, driving the stock's substantial pre-market gains.

While specific details of HC Wainwright's analysis were not immediately available, the maintained "Buy" rating suggests that the firm continues to see potential in Avidity Biosciences' business model and growth strategy. Investors are likely interpreting this as a positive sign for the company's future performance, leading to the notable increase in pre-market trading activity.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/news/1103800728"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"1103800728\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/1103800728?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-12 20:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"1103800728","market":"us","top_or_hot":-1,"title":"Stock Track | Avidity Biosciences (RNA) Soars 11.23% Pre-Market on HC Wainwright's Buy Rating Maintenance","media":"Stock Track","content":"<p>Shares of Avidity Biosciences, Inc. (RNA) are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its \"Buy\" rating on the company.</p>\n\n<p>The maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have sparked renewed interest among investors, driving the stock's substantial pre-market gains.</p>\n\n<p>While specific details of HC Wainwright's analysis were not immediately available, the maintained \"Buy\" rating suggests that the firm continues to see potential in Avidity Biosciences' business model and growth strategy. Investors are likely interpreting this as a positive sign for the company's future performance, leading to the notable increase in pre-market trading activity.</p>","source":"ai_movement_en","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Stock Track | Avidity Biosciences (RNA) Soars 11.23% Pre-Market on HC Wainwright's Buy Rating Maintenance</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nStock Track | Avidity Biosciences (RNA) Soars 11.23% Pre-Market on HC Wainwright's Buy Rating Maintenance\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1086803395\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Stock Track </p>\n<p class=\"h-time\">2025-05-12 20:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<p>Shares of Avidity Biosciences, Inc. (RNA) are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its \"Buy\" rating on the company.</p>\n\n<p>The maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have sparked renewed interest among investors, driving the stock's substantial pre-market gains.</p>\n\n<p>While specific details of HC Wainwright's analysis were not immediately available, the maintained \"Buy\" rating suggests that the firm continues to see potential in Avidity Biosciences' business model and growth strategy. Investors are likely interpreting this as a positive sign for the company's future performance, leading to the notable increase in pre-market trading activity.</p>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"RNA","symbol_name":"Avidity Biosciences, Inc.","start_time":0,"source_url":"","article_id":"1103800728","we_media_id":"1086803395","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=1103800728","pubTimestamp":1747051397,"columns":[],"sourceInfo":{"source_id":"ai_movement_en","name":"Stock Track"},"weMediaInfo":{"media_name":"Stock Track","introduction":"Track stock‘s movements and relevant news","home_visible":1,"id":"1086803395","head_image":"https://static.tigerbbs.com/a81accab1e7ee4144dc051f71903a390"},"summary":"Shares of Avidity Biosciences, Inc.  are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its \"Buy\" rating on the company.The maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have s","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"RNA":"Avidity Biosciences, Inc."},"translate_title":"HC Wainwright维持买入评级，Avidity Biosciences(RNA)盘前飙升11.23%","themeId":"","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"RNA":1},"content_text":"Shares of Avidity Biosciences, Inc. (RNA) are experiencing a significant pre-market surge on Monday, jumping 11.23% following a key analyst action. The biotechnology company's stock is attracting investor attention after HC Wainwright & Co. maintained its \"Buy\" rating on the company.\nThe maintenance of a positive outlook by a respected financial services firm like HC Wainwright & Co. often signals confidence in a company's future prospects. For Avidity Biosciences, this reaffirmation appears to have sparked renewed interest among investors, driving the stock's substantial pre-market gains.\nWhile specific details of HC Wainwright's analysis were not immediately available, the maintained \"Buy\" rating suggests that the firm continues to see potential in Avidity Biosciences' business model and growth strategy. Investors are likely interpreting this as a positive sign for the company's future performance, leading to the notable increase in pre-market trading activity.","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"movement","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}